Research Article

Prognostic Value of SYNTAX Score II in Patients with Acute Coronary Syndromes Referred for Invasive Management: A Subanalysis from the SPUM and COMFORTABLE AMI Cohorts

Table 3

Angiographic characteristics and medications.

VariablesSxSIILow <23SxSIIMid 23–32SxSIIHigh ≥23 value

Vessel involvement
LM2 (0.8)2 (0.8)10 (4.1)N/A
LAD121 (49.4)157 (64.1)181 (74.2)<0.001
LCx72 (29.4)83 (34)84 (34.4)0.419
RCA125 (51)126(51.6)134 (54.9)0.654

MVD# of vessels86 (35.1)106 (43.3)130 (53.3)<0.001
2 vessels72(29.4)71(29)83(34)
3 vessels14(5.7)35(14.3)47(19.3)

ACC/AHA lesion classification0.4130.413
Type A lesion15 (9.6)18 (11.7)10 (7.0)
Type B1 lesion73 (46.8)56 (36.4)60 (42.3)
Type B2 lesion41 (26.3)45 (29.2)37 (26.1)
Type C lesion27(17.3)35 (22.7)35 (24.6)

Restenotic lesion7 (2.9)6 (2.4)5 (2.1)0.876
Bifurcation lesion20 (8.3)28 (11.5)27 (11.2)0.441
Thrombus Procedural details132 (54.3)120(49)107(44.2)0.083
Length of 1st stent25.4 ± 520.2 ± 525.4 ± 5
Diameter of 1st stent3.03 ± 0.682.9 ± 0.412.81 ± 0.22
Length of 2nd stent19.85 ± 6.8323.6 ± 6.1218.2 ± 5.6
Diameter of 2nd stent3.1 ± 0.283 ± 0.682.6 ± 0.13
Length of 3rd stent15.9 ± 7.0212.4 ± 2.816.2 ± 9
Diameter of 3rd stent3.17 ± 0.312.95 ± 0.772.65 ± 0.48

TIMI flow0.207
TIMI 0107 (44.4)134 (54.9)128 (53.1)
TIMI I20 (8.3)15 (6.1)10 (4.1)
TIMI II38 (15.8)33 (13.5)36 (14.9)
TIMI III76 (31.5)62 (25.4)67 (27.8)

Medications on admission
ASA213 (86.9)205 (83.7)159 (65.7)<0.001
Clopidogrel6 (2.5)7 (2.9)14 (5.8)0.125
Prasugrel/ticagrelor1 (0.6)0 (0)0 (0)1
Statin34 (14)48 (19.6)63 (26.1)0.004
Beta blocker31(12.7)43 (17.6)68 (28.3)<0.001

Procedural antiplatelet Tx
Clopidogrel119 (69.2)120 (73.2)117 (73.6)0.451
Prasugrel63 (35.8)46 (28.0)26 (16.4)<0.001

Depicted are counts, n incidence (%) or mean ± SD.variables are included in the score; value reported as N/A. LAD, left anterior descending artery; RCA, right coronary artery; LCX, circumflex artery; TIMI, thrombolysis in myocardial infarction; AHA, American Heart Association.